Evidence map›Paper›PMID 31417640›Full record

ArticleJournal of Cancer2019

Risk Prediction for Early Mortality in Patients with Newly Diagnosed Primary CNS Lymphoma.

Chia-Hsin Lin, Ching-Fen Yang, Huai-Che Yang, Li-Yu Fay, Chiu-Mei Yeh, Ai-Seon Kuan, Hao-Yuan Wang, Jyh-Pyng Gau, Liang-Tsai Hsiao, Tzeon-Jye Chiou and 5 more

Abstract read
In one paragraph

Article in Journal of Cancer, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Prognostic value of POD18 combined with improved IELSG in primary central nervous system lymphoma.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Observational
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Chia-Hsin LinDepartment of Radiation Oncology, Linkou Chang Gung Memorial Hospital Medical Center, Taoyuan City, Taiwan.
Ching-Fen YangDepartment of Pathology and Laboratory Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
Huai-Che YangDepartment of Neurosurgery, Taipei Veterans General Hospital.
Li-Yu FayDepartment of Neurosurgery, Taipei Veterans General Hospital.
Chiu-Mei YehDivision of Hematology and Oncology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
Ai-Seon KuanCancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, OX3 7LF, UK.
Hao-Yuan WangSchool of Medicine, National Yang-Ming University, Taipei, Taiwan.
Jyh-Pyng GauSchool of Medicine, National Yang-Ming University, Taipei, Taiwan.
Liang-Tsai HsiaoSchool of Medicine, National Yang-Ming University, Taipei, Taiwan.
Tzeon-Jye ChiouSchool of Medicine, National Yang-Ming University, Taipei, Taiwan.
Po-Min ChenSchool of Medicine, National Yang-Ming University, Taipei, Taiwan.
Yao-Chung LiuSchool of Medicine, National Yang-Ming University, Taipei, Taiwan.
Po-Shen KoSchool of Medicine, National Yang-Ming University, Taipei, Taiwan.
Jin-Hwang LiuDivision of Hematology and Oncology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
Chia-Jen LiuDivision of Hematology and Oncology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Early mortalityepidemiologyprimary CNS lymphomaprognostic factors

Identifiers

PMID31417640
PMCPMC6692612

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.